Sotera Health Co has a consensus price target of $16.79, established from looking at the 39 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, RBC Capital, and RBC Capital on March 25, 2024, March 11, 2024, and March 4, 2024. With an average price target of $18.5 between Jefferies, RBC Capital, and RBC Capital, there's an implied 54.04% upside for Sotera Health Co from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/25/2024 | SHC | Buy Now | Sotera Health | $12.01 | 29.06% | Jefferies | David Windley | $15 → $15.5 | Upgrade | Hold → Buy | Get Alert |
03/11/2024 | SHC | Buy Now | Sotera Health | $12.01 | 66.53% | RBC Capital | Sean Dodge | → $20 | Reiterates | Outperform → Outperform | Get Alert |
03/04/2024 | SHC | Buy Now | Sotera Health | $12.01 | 66.53% | RBC Capital | Sean Dodge | → $20 | Reiterates | Outperform → Outperform | Get Alert |
02/28/2024 | SHC | Buy Now | Sotera Health | $12.01 | 58.2% | Barclays | Luke Sergott | $17 → $19 | Maintains | Overweight | Get Alert |
02/06/2024 | SHC | Buy Now | Sotera Health | $12.01 | — | Keybanc | Brett Fishbin | — | Initiates | → Sector Weight | Get Alert |
01/25/2024 | SHC | Buy Now | Sotera Health | $12.01 | 41.55% | Barclays | Luke Sergott | $15 → $17 | Maintains | Overweight | Get Alert |
11/02/2023 | SHC | Buy Now | Sotera Health | $12.01 | 66.53% | RBC Capital | Sean Dodge | $22 → $20 | Maintains | Outperform | Get Alert |
11/02/2023 | SHC | Buy Now | Sotera Health | $12.01 | 24.9% | Barclays | Luke Sergott | $20 → $15 | Maintains | Overweight | Get Alert |
08/04/2023 | SHC | Buy Now | Sotera Health | $12.01 | 83.18% | RBC Capital | Sean Dodge | $18 → $22 | Maintains | Outperform | Get Alert |
08/04/2023 | SHC | Buy Now | Sotera Health | $12.01 | 91.51% | Keybanc | Matthew Mishan | $24 → $23 | Maintains | Overweight | Get Alert |
06/26/2023 | SHC | Buy Now | Sotera Health | $12.01 | 99.83% | Keybanc | Matthew Mishan | → $24 | Upgrade | Sector Weight → Overweight | Get Alert |
06/22/2023 | SHC | Buy Now | Sotera Health | $12.01 | — | Keybanc | Matthew Mishan | — | Maintains | Sector Weight | Get Alert |
05/04/2023 | SHC | Buy Now | Sotera Health | $12.01 | 49.88% | RBC Capital | Sean Dodge | $19 → $18 | Maintains | Outperform | Get Alert |
05/04/2023 | SHC | Buy Now | Sotera Health | $12.01 | 66.53% | Barclays | Luke Sergott | $21 → $20 | Maintains | Overweight | Get Alert |
04/04/2023 | SHC | Buy Now | Sotera Health | $12.01 | 74.85% | Barclays | Luke Sergott | $22 → $21 | Maintains | Overweight | Get Alert |
03/01/2023 | SHC | Buy Now | Sotera Health | $12.01 | 58.2% | RBC Capital | Sean Dodge | $8 → $19 | Maintains | Outperform | Get Alert |
01/23/2023 | SHC | Buy Now | Sotera Health | $12.01 | 49.88% | JP Morgan | Tycho Peterson | $6 → $18 | Upgrade | Underweight → Neutral | Get Alert |
01/11/2023 | SHC | Buy Now | Sotera Health | $12.01 | 83.18% | Barclays | Luke Sergott | $6 → $22 | Upgrade | Underweight → Overweight | Get Alert |
01/11/2023 | SHC | Buy Now | Sotera Health | $12.01 | 108.16% | Wolfe Research | Mike Polark | → $25 | Upgrade | Peer Perform → Outperform | Get Alert |
The latest price target for Sotera Health (NASDAQ: SHC) was reported by Jefferies on March 25, 2024. The analyst firm set a price target for $15.50 expecting SHC to rise to within 12 months (a possible 29.06% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Sotera Health (NASDAQ: SHC) was provided by Jefferies, and Sotera Health upgraded their buy rating.
The last upgrade for Sotera Health Co happened on March 25, 2024 when Jefferies raised their price target to $15.5. Jefferies previously had a hold for Sotera Health Co.
The last downgrade for Sotera Health Co happened on November 16, 2022 when Barclays changed their price target from $7 to $6 for Sotera Health Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a upgraded with a price target of $15.00 to $15.50. The current price Sotera Health (SHC) is trading at is $12.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.